welcome to STERNA BIOLOGICALS

Treatment of type 2 inflammatory diseases by GATA-3 downregulation

LATEST PRESS RELEASES

Picture of the sterna bird

sterna biologicals

sterna biologicals is an innovative clinical-stage immunology company developing novel immunomodulation therapies for patients suffering from type 2 inflammatory diseases.

Read More
GATA3 molecule

The GATA-3 Approach

GATA-3 is a key master transcription factor in type 2 inflammation. GATA-3 downregulation could provide a novel, first-in-class anti-inflammatory treatment approach.

Read More
GATA3 Moleküle

Pipeline

sterna biologicals has a clinically validated development pipeline with lead candidates in asthma and ulcerative colitis.

Read More
GATA3 Moleküle

News & Events

Keep up to date with sterna biologicals – read our latest news and find out where you can meet us.

Read More
Contact icon

Contact

Interested in sterna biologicals? 
Get in touch!

Read More